Global Outlook for Excipients Bodes Well
Excipients market will be shaped by greater supply-chain concerns, quality-by-design programs,and overall drug-safety issues.
Moderate growth is expected for the global pharmaceutical market as technical issues, such as solubilization strategies, and quality issues, such as those relating to the supply chain and quality-by-design programs, influence growth.
The global market for pharmaceutical excipients was valued at $5.8 billion in 2012, and it is expected to reach $6.3 billion in 2013, according to the market research firm BCC Research. BCC projects the market for excipients will grow to $8.8 billion by 2018 and register a five-year compound annual growth rate of 6.9% from 2013 to 2018.
Pharmaceutical excipients serve various therapeutic-enhancing purposes, such as facilitating drug absorption or solubility, and the importance of these functionalities to a drug product are influencing growth. The forces that offer challenges to the global excipients industry in 2013 are problems in the global supply chain, the demands of QbD, and concerns about drug safety. These forces as well as increases in global usage of pharmaceuticals will continue to shape this market over the next five years.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
